Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116962) titled 'A clinical study to assess the effect of test product in people with prediabetes' on Sept. 3.
Study Type: Interventional
Study Design:
Randomized, Parallel Group, Placebo Controlled Trial Method of generating randomization sequence:Computer generated randomization Method of allocation concealment:Pre-numbered or coded identical Containers Blinding and masking:Participant and Investigator Blinded
Primary Sponsor: Finzelberg GmbH and Co. KG
Condition:
Health Condition 1: R730- Abnormal glucose
Intervention:
Intervention1: Recovera 600 mg Capsules: Ingredient Opuntia ficus indica
Dose 600 mg
Frequenc...